StockNews.com Initiates Coverage on Sorrento Therapeutics (NASDAQ:SRNE)
Research analysts at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report released on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Performance Shares of Sorrento Therapeutics stock opened at $0.00 on Wednesday. Sorrento Therapeutics has a 12 month low of […]
Research analysts at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report released on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Performance Shares of Sorrento Therapeutics stock opened at $0.00 on Wednesday. Sorrento Therapeutics has a 12 month low of […]
